SX
SXLV.AS SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF
51.29 EUR
Close of Oct 29, 2026
37.81
51.29
- Total assets
- 366M
- Expense ratio
- 0.15%
- Dividend yield
- 1.91%
- 1-year return
- +25.40%
- Holdings
- 10
- Since
- 2015
Fund data as reported by the issuer, updated Oct 28, 2026. Total assets are in the fund's base currency.
What does SXLV.AS invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (96.1%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (100.0%)
- Top 3 holdings: 33.3% of the fund
Asset allocation
- US stocks 96.1%
- Cash 0.2%
Top holdings
- Eli Lilly and Company 14.82%
- Johnson & Johnson 10.68%
- AbbVie Inc 7.79%
- Merck & Company Inc 5.76%
- UnitedHealth Group Incorporated 5.41%
SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF performance
Sharpe ratio 0.46- This year
- +16.55%
- 1 year
- +25.40%
- 3 years
- +14.67%
- 5 years
- +7.37%
Volatility 15.4% over 1 year and 14.6% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
SXLV.AS price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF top holdings
60.4% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Eli Lilly and Company LLY.US | Healthcare | United States | 14.82% |
| Johnson & Johnson JNJ.US | Healthcare | United States | 10.68% |
| AbbVie Inc ABBV.US | Healthcare | United States | 7.79% |
| Merck & Company Inc MRK.US | Healthcare | United States | 5.76% |
| UnitedHealth Group Incorporated UNH.US | Healthcare | United States | 5.41% |
| Thermo Fisher Scientific Inc TMO.US | Healthcare | United States | 3.96% |
| Amgen Inc AMGN.US | Healthcare | United States | 3.76% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 2.91% |
| Abbott Laboratories ABT.US | Healthcare | United States | 2.75% |
| Pfizer Inc PFE.US | Healthcare | United States | 2.55% |
SXLV.AS sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
SXLV.AS regional exposure
- North America100.0%
Share of the stocks in the fund.
Company size
Average market cap 206B- Mega cap14.8%
- Big cap60.3%
- Medium cap21.4%
- Small cap1.8%
SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF fund profile
- Fund name
- SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF
- Ticker
- SXLV.AS
- Exchange
- Euronext Amsterdam
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Jul 7, 2015
- Trading currency
- EUR
- Expense ratio
- 0.15%